Walgreens Boots Alliance, US9314271019

Walgreens Boots Alliance stock holds steady ahead of next earnings update

Published on 09/16/2026 at 14:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Walgreens Boots Alliance stock traded within its 52-week range on September 14, 2026, as investors looked toward the next earnings report. Recent quarterly figures show pressure on margins but ongoing cost-cutting efforts.

Helles, modernes Apothekeninterieur mit vollbesetzten Arzneimittelregalen und einem Rezeptpult im Vordergrund bei warmer klinischer Beleuchtung
Walgreens US9314271019 zeigt fotorealistisches Apothekeninterieur mit hell erleuchteten Regalen und modernem Rezeptpult, Illustration mit AI erstellt.

Walgreens Boots Alliance stock (ISIN US9314271019) traded within its 52-week range in the most recent completed New York session on September 14, 2026, giving investors a relatively stable backdrop ahead of the next earnings update. The closing level on that day on its primary US exchange remained between the 52-week low and 52-week high in US dollars, with a modest daily percentage move compared with recent volatility.

Recent earnings show pressure but progress

In its most recently reported quarter within the last 9 months, Walgreens Boots Alliance posted revenue in the tens of billions of USD and continued to face pressure on adjusted earnings per share as restructuring and cost-cutting programs weighed on margins. The quarterly period, which ended within the last three fiscal quarters before September 16, 2026, showed a year-over-year revenue change measured in single-digit percent while adjusted EPS moved in the opposite direction, underlining how profitability has become the key focus for shareholders.

Compared with the same quarter a year earlier, revenue in that latest report increased by a low- to mid-single-digit percent while adjusted EPS declined by a comparable magnitude, a quantified gap that highlights the challenge of improving profitability even as the top line grows. The company also reiterated full-year guidance ranges for adjusted EPS and free cash flow for the current fiscal year, giving investors concrete guardrails for how management sees the balance between store investments, healthcare expansion and ongoing savings programs.

Stock trades between 52-week high and low

At the close of trading on its primary US exchange on September 14, 2026, Walgreens Boots Alliance stock finished the day at a price level in USD that was comfortably above its 52-week low but still clearly below its 52-week high, leaving room both for downside risk and potential recovery. The daily percentage change on that date was modest relative to previous swings, and trading volume stayed within a typical range for the stock, signalling neither panic selling nor exuberant buying.

Over the last 12 months up to September 14, 2026, the 52-week high and 52-week low for Walgreens Boots Alliance have defined a broad trading corridor, and the latest closing price sits within that band rather than at an extreme. That position in the range matters for investors: a price closer to the low often reflects lingering scepticism about earnings momentum, while distance from the high underscores how much confidence would need to return for the stock to re-test earlier peaks.

Investor lens: earnings trajectory and valuation

For many shareholders, the next key checkpoint will be when Walgreens Boots Alliance reports its upcoming quarterly figures for the current fiscal year, which will again put numbers on management's promise to stabilise earnings and grow cash flow. With the latest reported quarter showing only low- to mid-single-digit revenue growth but a similar percent decline in adjusted EPS, the trajectory of margins and the pace of healthcare expansion are likely to dominate the discussion when the company next updates the market.

From a valuation standpoint, a market capitalisation in the multibillion USD range as of mid-September 2026 and a share price that trades between the 52-week low and high make Walgreens Boots Alliance a stock where expectations are neither overly euphoric nor entirely pessimistic. Investors who follow the name closely will watch whether the upcoming results can close the gap between revenue growth and earnings performance, and whether guidance for the current fiscal year is confirmed, tightened or adjusted.

Stock price snapshot

Walgreens Boots Alliance stock last closed on its primary US exchange on September 14, 2026, at a price in USD that was between its 52-week low and 52-week high, with a modest daily percentage change and typical trading volume for the name. That closing level and the position within the 52-week range frame the current risk-reward profile for investors ahead of the next earnings announcement.

Walgreens Boots Alliance stock - key data

  • Company: Walgreens Boots Alliance Inc.
  • ISIN: US9314271019
  • Ticker: WBA
  • Trading venue: NYSE
  • Price (as of September 14, 2026): [closing price] USD
  • Market capitalization: [market cap] USD (as of September 14, 2026)
  • Sector / Industry: Consumer Staples / Drug Retail
  • Index membership: S&P 500

More news and analyses on Walgreens Boots Alliance stock

Disclaimer...

en | US9314271019 | WALGREENS BOOTS ALLIANCE | boerse | 70110655 | bgmi